ברקלוד 1 מ"ג

Country: Իսրայել

language: եբրայերեն

source: Ministry of Health

active_ingredient:

ENTECAVIR 1 MG

MAH:

BRISTOL, MYERS SQUIBB (ISRAEL) LIMITED

ATC_code:

J05AF10

pharmaceutical_form:

FILM COATED TABLETS

administration_route:

PER OS

manufactured_by:

BRISTOL MYERS SQUIBB SPA, ITALY

therapeutic_group:

ENTECAVIR

therapeutic_indication:

Baraclude is indicated for the treatment of chronic hepatitis B virus (HBV) infection in adults with compensated liver disease and evidence of active viral replication, and persistently elevated serum alanine aminotransferase (ALT) levels. This indication is based on clinical trial data in patients with HBeAg positive and HBeAg negative HBV infection, nucleoside naive patients and patients with lamivudine-refractory hepatitis B.Decompensated liver disease.

authorization_date:

2009-02-01